Tetragenetics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tetragenetics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10572
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tetragenetics Inc (Tetragenetics) is a biotechnology company that discovers and develops therapeutics for autoimmune disease and pain. The company develops antibodies for autoimmune disorders, pains and other. Its autoimmune disorders include Type 1 Diabetes Mellitus, rheumatoid arthritis, multiple sclerosis, psoriasis, lupus and others. The company’s drug developing technologies comprise ion channels, tetraexpress, and antibody discovery. Tetragenetics has partnered with various companies for drug discovery. The company provides drug discovery and development programs channels included in pathogenesis of autoimmunity and pain. Tetragenetics is headquartered in Arlington, Massachusetts, the US.

Tetragenetics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
TetraGenetics Raises Funds through Venture Financing 11
Tetragenetics Raises USD1 Million in Venture Financing 12
Tetragenetics Raises USD0.3 Million in Financing Round 13
Tetragenetics Raises US$0.5 Million In Venture Financing 14
Tetragenetics Raises US$3 Million In Venture Financing 15
Partnerships 16
Tetragenetics Enters into Agreement with LifeArc 16
Tetragenetics Enters into Partnership with Modiquest Research 17
Tetragenetics Enters into Agreement with Theranyx 18
Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics 19
Tetragenetics Enters into Agreement with MedImmune for Drug Discovery Program 20
Licensing Agreements 21
Tetragenetics Enters Into Option For Licensing Agreement With Pfizer For SionX Technology 21
Tetragenetics Enters Into Licensing Agreement With Amgen For Antibodies 22
Tetragenetics Inc – Key Competitors 23
Tetragenetics Inc – Key Employees 24
Tetragenetics Inc – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Tetragenetics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TetraGenetics Raises Funds through Venture Financing 11
Tetragenetics Raises USD1 Million in Venture Financing 12
Tetragenetics Raises USD0.3 Million in Financing Round 13
Tetragenetics Raises US$0.5 Million In Venture Financing 14
Tetragenetics Raises US$3 Million In Venture Financing 15
Tetragenetics Enters into Agreement with LifeArc 16
Tetragenetics Enters into Partnership with Modiquest Research 17
Tetragenetics Enters into Agreement with Theranyx 18
Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics 19
Tetragenetics Enters into Agreement with MedImmune for Drug Discovery Program 20
Tetragenetics Enters Into Option For Licensing Agreement With Pfizer For SionX Technology 21
Tetragenetics Enters Into Licensing Agreement With Amgen For Antibodies 22
Tetragenetics Inc, Key Competitors 23
Tetragenetics Inc, Key Employees 24

List of Figures
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tetragenetics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Credit Saison Co., Ltd.:企業の戦略・SWOT・財務分析
    Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • DiaMedica Therapeutics Inc (DMA):医療機器:M&Aディール及び事業提携情報
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • MediGene AG (MDG1):企業の財務・戦略的SWOT分析
    MediGene AG (MDG1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Brunei National Petroleum Company Sendirian Berhad:石油・ガス:M&Aディール及び事業提携情報
    Summary Brunei National Petroleum Company Sendirian Berhad (PetroleumBRUNEI) is an oil and gas company that provides exploration and production of oil and gas. The company offers engineering, procurement, construction, installation, commissioning services, and others. It provides oilfield services, …
  • Tokyo Electric Power Company Holdings Incorporated (9501):電力:M&Aディール及び事業提携情報
    Summary Tokyo Electric Power Company Holdings Incorporated (TEPCO) is an energy utility. It generates, transmits and distributes electricity; transports fuel; and retails electricity and gas. The company produces power using coal, gas, LNG, solar, wind and hydro sources. TEPCO has presence in the en …
  • eHealthInsurance Services Inc:企業の戦略的SWOT分析
    eHealthInsurance Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Sanford Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding d …
  • Lotus Pharmaceutical Co Ltd (1795):企業の財務・戦略的SWOT分析
    Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman hea …
  • Galp Energia SGPS SA (GALP):企業の財務・戦略的SWOT分析
    Galp Energia SGPS SA (GALP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as beleodaq and asidna among others. It offers drugs for the treatment of liver cancer, and treatment and pr …
  • White Mountains Insurance Group Ltd:企業のM&A・事業提携・投資動向
    White Mountains Insurance Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's White Mountains Insurance Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Aveda Transportation and Energy Services Inc (AVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Aveda Transportation and Energy Services Inc (Aveda), formerly Phoenix Oilfield Hauling Inc is an oilfield service provider that offers energy transportation and other energy related services. The company provides specialized transportation services and equipment for drilling, exploration, d …
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務情報
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Austin Industries Inc:企業の戦略・SWOT・財務分析
    Austin Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Austin Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • KOSE Corp:企業の戦略・SWOT・財務情報
    KOSE Corp - Strategy, SWOT and Corporate Finance Report Summary KOSE Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • GeoPark Ltd (GPRK):石油・ガス:M&Aディール及び事業提携情報
    Summary GeoPark Ltd (GeoPark) is an oil and gas exploration and production company that explores, develops and produces upstream oil and gas in Latin America. The company operates various blocks such as Colombia blocks, Chile blocks, Brazil blocks, Peru blocks and Argentina blocks. Its Colombia bloc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆